Jaroentomeechai, Thapakorn
Kwon, Yong Hyun http://orcid.org/0000-0002-0070-2382
Liu, Yiwen
Young, Olivia
Bhawal, Ruchika http://orcid.org/0000-0002-5705-5032
Wilson, Joshua D.
Li, Mingji http://orcid.org/0000-0003-2455-3307
Chapla, Digantkumar G.
Moremen, Kelley W. http://orcid.org/0000-0003-1768-582X
Jewett, Michael C. http://orcid.org/0000-0003-2948-6211
Mizrachi, Dario
DeLisa, Matthew P. http://orcid.org/0000-0003-3226-1566
Funding for this research was provided by:
Bill and Melinda Gates Foundation (OPP1217652)
United States Department of Defense | Defense Threat Reduction Agency (HDTRA1-15-10052 and HDTRA1-20-10004)
National Science Foundation (CBET-1159581, CBET-1264701, CBET-1936823 and MCB-1413563)
U.S. Department of Health & Human Services | National Institutes of Health (1R01GM137314 and 1R01GM127578)
Article History
Received: 17 January 2022
Accepted: 11 October 2022
First Online: 24 October 2022
Competing interests
: M.P.D. has a financial interest in Gauntlet Bio, Inc., Glycobia, Inc., SwiftScale Biologics, Inc., Versatope, Inc., and UbiquiTx, Inc. M.C.J. has a financial interest in Gauntlet Bio, Inc. and SwiftScale Biologics, Inc.. M.P.D.’s and M.C.J.’s interests are reviewed and managed by Cornell University and Northwestern University, respectively, in accordance with their conflict-of-interest policies. M.P.D. and M.C.J. have no non-financial competing interests to declare. All other authors declare no competing interests.